FI117961B - Nopeasti vaikutuksen aloittava formulaatio - Google Patents

Nopeasti vaikutuksen aloittava formulaatio Download PDF

Info

Publication number
FI117961B
FI117961B FI20021708A FI20021708A FI117961B FI 117961 B FI117961 B FI 117961B FI 20021708 A FI20021708 A FI 20021708A FI 20021708 A FI20021708 A FI 20021708A FI 117961 B FI117961 B FI 117961B
Authority
FI
Finland
Prior art keywords
pyridoxine
hcl
weight
minutes
doxylamine succinate
Prior art date
Application number
FI20021708A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20021708A (fi
FI20021708A0 (fi
Inventor
Eric Gervais
Original Assignee
Duchesnay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42104724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI117961(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Duchesnay Inc filed Critical Duchesnay Inc
Publication of FI20021708A0 publication Critical patent/FI20021708A0/fi
Publication of FI20021708A publication Critical patent/FI20021708A/fi
Application granted granted Critical
Publication of FI117961B publication Critical patent/FI117961B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Seal Device For Vehicle (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Power Steering Mechanism (AREA)
FI20021708A 2000-12-20 2002-09-25 Nopeasti vaikutuksen aloittava formulaatio FI117961B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CA002350195A CA2350195C (en) 2000-12-20 2000-12-20 Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
CA2350195 2000-12-20
CA0100951 2001-06-21
PCT/CA2001/000951 WO2003000263A1 (en) 2000-12-20 2001-06-21 Rapid onset formulation
US88505101 2001-06-21
US09/885,051 US6340695B1 (en) 2000-12-20 2001-06-21 Rapid onset formulation

Publications (3)

Publication Number Publication Date
FI20021708A0 FI20021708A0 (fi) 2002-09-25
FI20021708A FI20021708A (fi) 2002-12-22
FI117961B true FI117961B (fi) 2007-05-15

Family

ID=42104724

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20021708A FI117961B (fi) 2000-12-20 2002-09-25 Nopeasti vaikutuksen aloittava formulaatio

Country Status (35)

Country Link
US (1) US6340695B1 (de)
EP (1) EP1397133B1 (de)
JP (1) JP4242763B2 (de)
KR (1) KR100527985B1 (de)
CN (1) CN1229112C (de)
AT (1) ATE307582T1 (de)
AU (1) AU2001272243B2 (de)
BE (1) BE1014929A4 (de)
BR (1) BR0107371A (de)
CA (1) CA2350195C (de)
DE (2) DE60114475T2 (de)
DK (2) DK1397133T3 (de)
EG (1) EG24483A (de)
ES (1) ES2251494T3 (de)
FI (1) FI117961B (de)
FR (1) FR2826277B1 (de)
GB (1) GB2383751C (de)
GR (1) GR1004371B (de)
HK (1) HK1052654A1 (de)
HU (1) HU227003B1 (de)
IL (1) IL150349A0 (de)
IS (1) IS2225B (de)
IT (1) ITTO20020524A1 (de)
LU (1) LU90934B1 (de)
MC (1) MC200059A1 (de)
MX (1) MXPA02006037A (de)
MY (1) MY132786A (de)
NL (1) NL1020895C2 (de)
NO (1) NO332190B1 (de)
PL (1) PL204507B1 (de)
SE (1) SE526307C2 (de)
TR (1) TR200201685T1 (de)
UA (1) UA74807C2 (de)
UY (1) UY27352A1 (de)
WO (1) WO2003000263A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
US8257746B2 (en) 2001-04-10 2012-09-04 Pernix Therapeutics, Llc Tannate compositions, methods of making and methods of use
US8012506B2 (en) * 2001-04-10 2011-09-06 Pernix Therapeutics, Llc Tannate compositions, methods of making and methods of use
ES2229876B1 (es) * 2001-06-26 2006-03-01 Duchesnay Inc. Formulacion de accion rapida.
CA2392486A1 (en) * 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
JP2004231520A (ja) * 2003-01-28 2004-08-19 Nichiko Pharmaceutical Co Ltd 保存安定性及び溶出速度に優れた医薬組成物
US20050004181A1 (en) * 2003-07-03 2005-01-06 Duchesnay Inc. Use of anti-emetic for pre and post operative care
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US8481565B2 (en) * 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
KR101213345B1 (ko) * 2005-04-28 2012-12-17 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매약을 함유하는 조성물
US20070277530A1 (en) * 2006-05-31 2007-12-06 Constantin Alexandru Dinu Inlet flow conditioner for gas turbine engine fuel nozzle
CN102108059B (zh) * 2010-09-03 2012-05-09 合肥工业大学 一种琥珀酸多西拉敏的合成方法
US8950188B2 (en) 2011-09-09 2015-02-10 General Electric Company Turning guide for combustion fuel nozzle in gas turbine and method to turn fuel flow entering combustion chamber
WO2013123569A1 (en) * 2012-02-22 2013-08-29 Duchesnay Inc. Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
EP2787971A4 (de) * 2012-02-22 2015-04-29 Duchesnay Inc Formulierung aus doxylamin und pyridoxin und/oder metaboliten oder salzen davon
WO2013172297A1 (ja) 2012-05-14 2013-11-21 塩野義製薬株式会社 ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有製剤
US9452181B2 (en) 2013-07-22 2016-09-27 Duchesnay Inc. Composition for the management of nausea and vomiting
MX366760B (es) 2013-07-22 2019-07-23 Duchesnay Inc Composición para la gestión de las náuseas y los vómitos.
CN103432126A (zh) * 2013-08-05 2013-12-11 北京阜康仁生物制药科技有限公司 一种治疗孕吐的药物组合物
TWI595874B (zh) 2014-08-29 2017-08-21 達契斯奈股份有限公司 多西拉敏及吡哆醇及／或其代謝產物或鹽之多模式釋放調配物
PT3185856T (pt) * 2014-08-29 2018-10-09 Duchesnay Inc Formulação de libertação plurimodal de doxilamina e pirodoxina e/ou seus metabolitos ou sais
WO2017029573A1 (en) 2015-08-17 2017-02-23 Aequus Pharmaceuticals Inc. Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride
CN105510512B (zh) * 2016-01-25 2018-06-29 南京济群医药科技股份有限公司 一种琥珀酸多西拉敏有关物质的rt-hplc检测方法
PL3628311T3 (pl) * 2018-09-27 2021-07-05 Inibsa Ginecologia, S.A. Sposób wytwarzania doustnej wielojednostkowej postaci dawkowanej bursztynianu doksylaminy i chlorowodorku pirydoksyny o zmodyfikowanym uwalnianiu
CN114099450A (zh) * 2020-08-31 2022-03-01 长春海悦药业股份有限公司 一种比拉斯汀片及其制备方法
AU2021225255B1 (en) * 2021-09-03 2022-06-16 Patel, Mihir MR Compositions, kits, and methods to provide synergistic and/or additive effects from comprised ingredients for the prevention, treatment and management of nausea and vomiting.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2085641A1 (en) * 1970-04-20 1971-12-31 Investigations Sci Pharm Noramidopyrine doxylamine succinate compsn - antiinflammatories analgesics and antipyretics
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength
CA2139896C (en) * 1995-01-10 2000-03-28 Don B. Mcdonah Use of antinauseant agent for terminally ill humans
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
WO2001019901A2 (en) * 1999-09-14 2001-03-22 Smithkline Beecham Corporation Process for making aqueous coated beadlets
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate

Also Published As

Publication number Publication date
NL1020895C2 (nl) 2003-03-13
EP1397133A1 (de) 2004-03-17
GB2383751A (en) 2003-07-09
PL204507B1 (pl) 2010-01-29
CA2350195C (en) 2003-06-10
ITTO20020524A0 (it) 2002-06-18
UA74807C2 (en) 2006-02-15
SE0202061L (sv) 2003-01-28
NO332190B1 (no) 2012-07-23
KR20030023612A (ko) 2003-03-19
DK1397133T3 (da) 2006-02-27
FR2826277A1 (fr) 2002-12-27
MC200059A1 (fr) 2003-01-30
SE0202061D0 (sv) 2002-07-03
IS2225B (is) 2007-04-15
CN1229112C (zh) 2005-11-30
GB2383751B (en) 2005-02-09
ES2251494T3 (es) 2006-05-01
DK176018B1 (da) 2005-12-05
BE1014929A4 (fr) 2004-06-01
CN1447694A (zh) 2003-10-08
GB0213990D0 (en) 2002-07-31
DE60114475D1 (de) 2005-12-01
FI20021708A (fi) 2002-12-22
JP4242763B2 (ja) 2009-03-25
ATE307582T1 (de) 2005-11-15
MXPA02006037A (es) 2005-05-12
GR1004371B (el) 2003-10-23
UY27352A1 (es) 2002-09-30
DK200200947A (da) 2003-01-03
DE60114475T2 (de) 2006-07-13
FI20021708A0 (fi) 2002-09-25
NO20022982D0 (no) 2002-06-20
ITTO20020524A1 (it) 2003-12-18
HK1052654A1 (en) 2003-09-26
WO2003000263A1 (en) 2003-01-03
IE20020488A1 (en) 2003-04-30
FR2826277B1 (fr) 2004-07-02
MY132786A (en) 2007-10-31
BR0107371A (pt) 2003-06-10
IL150349A0 (en) 2003-12-23
LU90934B1 (fr) 2002-12-23
IS6412A (is) 2002-12-22
DE10196426T1 (de) 2003-08-21
JP2004521146A (ja) 2004-07-15
HUP0301950A2 (hu) 2003-11-28
GR20020100280A (el) 2003-03-28
EG24483A (en) 2009-08-09
SE526307C2 (sv) 2005-08-16
TR200201685T1 (tr) 2003-06-23
NL1020895A1 (nl) 2002-12-30
HUP0301950A3 (en) 2005-06-28
PL362763A1 (en) 2004-11-02
EP1397133B1 (de) 2005-10-26
US6340695B1 (en) 2002-01-22
NO20022982L (no) 2002-10-09
KR100527985B1 (ko) 2005-11-09
HU227003B1 (en) 2010-04-28
GB2383751C (en) 2008-08-05
AU2001272243B2 (en) 2004-02-05
CA2350195A1 (en) 2001-08-11

Similar Documents

Publication Publication Date Title
FI117961B (fi) Nopeasti vaikutuksen aloittava formulaatio
JP5144527B2 (ja) 改良された安定性と生物学的利用能をもつ塩酸パロノセトロンの投与形態
TW550076B (en) Sustained release formulations
US20080268057A1 (en) Controlled release carvedilol compositions
WO2006070781A1 (ja) 塩基性薬物又はその塩を含有するマトリックス型徐放性製剤およびその製造方法
MXPA05001538A (es) Distribuidor de tipo manguito de endoscopio.
AU2001272243A1 (en) Rapid onset formulation
KR100591142B1 (ko) 파록세틴을 활성물질로 함유하는 장용성 서방형 정제
US9114085B2 (en) Modified release pharmaceutical compositions of dexlansoprazole
WO2002036077A2 (en) Once a day antihistamine and decongestant formulation
CN109890372B (zh) 含埃索美拉唑的复合胶囊及其制备方法
KR102190173B1 (ko) Ｎｓａｉｄ 투여 및 관련 조성물, 방법 및 시스템
WO2004062552A2 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
TW201127816A (en) 4-methylpyrazole formulations
WO2009027786A2 (en) Matrix dosage forms of varenicline
CA2854612C (en) Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts
EP3331505B1 (de) Pharmazeutische zusammensetzung mit einem atypischen antipsychotischen wirkstoff und verfahren zur herstellung davon
US20210169807A1 (en) Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
RU2266744C2 (ru) Композиция быстрого начала действия
KR20240090519A (ko) 시프로플록사신 및 셀레콕시브를 포함하는 조성물
EP2236159A2 (de) Dimebolin enthaltende Zusammensetzungen mit modifizierter Freisetzung
SA02230170B1 (ar) تركيبة سريعة الانبعاث
US20050095286A1 (en) Extended release compositions
NZ519709A (en) Rapid onset formulation comprising pyridoxine HCL and doxylamine succinate
TW201609197A (zh) 每日一次投藥之提供藥學及臨床效果之莫沙必利持續釋放製劑

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117961

Country of ref document: FI

MA Patent expired